To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Idinvest, Gimv-backed Prosensa soars after IPO
The Dutch biotech company is now valued at around $670 million, after its shares gained 48 percent in their first day of trading.
